Back

StatPearls, LLC

  • Antibodies, Antinuclear
  • Arthralgia
  • Fever
  • Lupus Erythematosus, Systemic
  • Myalgia

Drug-Induced Lupus Erythematosus

Drug-induced lupus is an autoimmune syndrome precipitated by exposure to specific medications and characterized by clinical and serologic features that resemble idiopathic systemic lupus erythematosus. Common manifestations include arthralgia, myalgia, fever, serositis, and fatigue, while renal and central nervous system involvement occur less frequently than in primary lupus. Serologic evaluation typically demonstrates a positive antinuclear antibody test, often with antihistone antibodies, supporting diagnostic differentiation. Withdrawal of the offending medication usually leads to symptom resolution, distinguishing drug-induced lupus as a reversible condition. The increasing use of biologics, targeted therapies, and cancer immunotherapies has expanded the spectrum of implicated agents, underscoring the need for heightened clinical awareness and accurate identification. Course participants gain practical knowledge to identify medications associated with drug-induced lupus, distinguish clinical and laboratory features of drug-induced lupus from those of idiopathic systemic lupus erythematosus, and select appropriate diagnostic testing. Clinicians develop skills in timely diagnosis, medication reconciliation, and evidence-based management, including decisions regarding drug discontinuation and adjunctive therapy when indicated. Emphasis is placed on reducing unnecessary testing and preventing delays in care. Collaboration within an interprofessional healthcare team, including pharmacists, nurses, primary care clinicians, and specialists, is highlighted as enhancing medication surveillance, diagnostic accuracy, and care coordination. Team-based communication supports early recognition, appropriate intervention, and improved patient outcomes while minimizing morbidity associated with delayed or missed diagnoses.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 6 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left